<?xml version="1.0" encoding="UTF-8"?>
<ref id="bph15092-bib-0052">
 <mixed-citation publication-type="journal" id="bph15092-cit-0053">
  <string-name>
   <surname>Li</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Xing</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Yang</surname>, 
   <given-names>Y.</given-names>
  </string-name>, 
  <string-name>
   <surname>Liu</surname>, 
   <given-names>J.</given-names>
  </string-name>, 
  <string-name>
   <surname>Wang</surname>, 
   <given-names>W.</given-names>
  </string-name>, 
  <string-name>
   <surname>Xia</surname>, 
   <given-names>Y.</given-names>
  </string-name>, … 
  <string-name>
   <surname>Shen</surname>, 
   <given-names>F.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>Adjuvant (131)I‐metuximab for hepatocellular carcinoma after liver resection: A randomised, controlled, multicentre, open‐label, phase 2 trial</article-title>. 
  <source xml:lang="en">The Lancet Gastroenterology &amp; Hepatology</source>, 
  <volume>5</volume>(
  <issue>6</issue>), 
  <fpage>548</fpage>–
  <lpage>560</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S2468-1253(19)30422-4</pub-id>
  <pub-id pub-id-type="pmid">32164877</pub-id>
 </mixed-citation>
</ref>
